Management of ovarian hyperstimulation syndrome. Produced on behalf of the BFS Policy and Practice Committee

References

• Aboulghar, M.A., Mansour, R.T., Serour, G.I., & Amin, Y. (1990). Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fertility and Sterility, 53, 933–935.
   PubMed Web of Science ®Google Scholar
• Abramov, Y., Barak, V., Nisman, B., & Schenker, J.G. (1997). Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertility and Sterility, 67, 261–265.
   PubMed Web of Science ®Google Scholar
• Abramov, Y., Elchalal, U., & Schenker, J.G. (1998). Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertility and Sterility, 70, 1070–1076.
   PubMed Web of Science ®Google Scholar
• Abramov, Y., Elchalal, U., & Schenker, J.G. (1999a). Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertility and Sterility, 71, 645–651.
   PubMed Web of Science ®Google Scholar
• Abramov, Y., Elchalal, U., & Schenker, J.G. (1999b). An ‘epidemic’ of severe OHSS – a price we have to pay?Human Reproduction, 14, 2181–2183.
   PubMed Web of Science ®Google Scholar
• Abramov, Y., Fatum, M., Abrahamov, D., & Schenker, J.G. (2001). Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Fertility and Sterility, 75, 1228–1230.
   Google Scholar
• Abuzeid, M.I., Nassar, Z., Massaad, Z., Weiss, M., Ashraf, M., & Fakih, M. (2003). Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome.Human Reproduction, 18, 370–373.
   PubMed Web of Science ®Google Scholar
• Al-Ramahi, M., Leader, A., Claman, P., & Spence, J. (1997). A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome. Human Reproduction, 12, 2614–2616.
   PubMed Web of Science ®Google Scholar
• Ando, H., Furugori, K., Shibata, D., Harata, T., Murata, Y., & Mizutani, S. (2003). Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series. Human Reproduction, 18, 1219–1222.
   PubMed Web of Science ®Google Scholar
• Ata, B., Yakin, K., Alatas, C., & Urman, B. (2008). Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome. Fertility and Sterility, 90, 531–536.
   PubMed Web of Science ®Google Scholar
• Ayus, J.C., Krothapalli, R.K., & Arieff, A.I. (1987). Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. New England Journal of Medicine, 317, 1190–1195.
   PubMed Web of Science ®Google Scholar
• Balasch, J., Carmona, F., Llach, J., Arroyo, V., Jove, I., & Vanrell, J.A. (1990). Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. Human Reproduction, 5, 348–351.
   PubMed Web of Science ®Google Scholar
• Bates, S.M., Greer, I.A., Middledorp, S., Veenstra, D.L., Prabulos, A.-M., & Vandvik, P.O. (2012). VTE, thrombophilia, antithrombotic therapy and prevention of thrombosis: Americal College of Chest Physicians Evidence-based clinical practice guidelines. Chest, 141, e691S–e736S.
   Web of Science ®Google Scholar
• Braat, D.D.M., Schutte, J.M., Bernardus, R.E., Mooij, T.M., & van Leeuwen, F.E. (2010). Maternal death related to IVF in the Netherlands 1984–2008. Human Reproduction, 25, 1782–1786.
   Google Scholar
• Cheatham, M.L. (2009). Abdominal compartment syndrome. Current Opinion in Critical Care, 15, 154–162.
   Google Scholar
• Chen, C.D., Yang, J.H., Chao, K.H., Chen, S.U., Ho, H.N., & Yang, Y.S. (1998). Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome. Human Reproduction, 13, 2077–2081.
   PubMed Web of Science ®Google Scholar
• Cil, T., Tummon, I.S., House, A.A., Taylor, B., Hooke, G., Franklin, J., et al. (2000). A tale of two syndromes: ovarian hyperstimulation and abdominal compartment. Human Reproduction, 15, 1058–1060.
   PubMed Web of Science ®Google Scholar
• Csokmay, J.M., Yauger, B.J., Henne, M.B., Armstrong, A.Y., Queenan, J.T., & Segars, J.H. (2010). Cost analysis model of outpatient mana gement of ovarian hyperstimulation syndrome with paracentesis: “Tap early and often” versus hospitalization. Fertility and Sterility, 93, 167–173.
   PubMed Web of Science ®Google Scholar
• Delbaere, A., Smits, G., De Leener, A., Costagliola, S., & Vassart, G. (2005). Understanding ovarian hyperstimulation syndrome. Endocrine, 26, 285–290.
   PubMed Web of Science ®Google Scholar
• Delvigne, A., Demoulin, A., Smitz, J., Donnez, J., Koinckx, P., Dhont, M., Englert, Y., Delbeke, L., Darcis, L., Gordts, S., et al. (1993). The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Human Reproduction, 8, 1353–1360.
   PubMed Web of Science ®Google Scholar
• Delvigne, A. & Rosenberg S. (2003). Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Human Reproduction Update, 9, 77–96.
   PubMed Web of Science ®Google Scholar
• Delvigne, A. & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update, 8, 559–577.
   PubMed Web of Science ®Google Scholar
• Derkx, F.H., Alberda, A.T., Zeilmaker, G.H., & Schalekamp, M.A. (1987). High concentrations of immunoreactive renin, prorenin and enzymatically-active renin in human ovarian follicular fluid. British Journal of Obstetrics and Gynaecology, 94, 4–9.
   PubMedGoogle Scholar
• Enskog, A., Henriksson, M., Unander, M., Nilsson, L., & Brannstrom, M. (1999). Prospective study of the clinical and laboratory para meters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertility and Sterility, 71, 808–814.
   PubMed Web of Science ®Google Scholar
• Evbuomwan, I.O., Davison, J.M., & Murdoch, A.P. (2000). Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. Fertility and Sterility, 74, 67–72.
   PubMedGoogle Scholar
• Fabregues, F., Balasch, J., Ginès, P., Manau, D., Jiménez, W., Arroyo, V., et al. (1999). Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome. American Journal of Gastroenterology, 94, 994–999.
   PubMedGoogle Scholar
• Ferrara, N. & Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocrine Reviews, 18, 4–25.
   PubMed Web of Science ®Google Scholar
• Ferrareti, A.P., Gianaroli, L., Diotallevi, L., Festi, C., & Trounson, A. (1992). Dopamine treatment for severe ovarian hyperstimulation syndrome. Human Reproduction, 7, 180–183.
   Google Scholar
• Fluker, M.R., Copeland, J.E., & Yuzpe, A.A. (2000). An ounce of prevention: outpatient management of the ovarian hyper stimulation syndrome. Fertility and Sterility, 73, 821–824.
   Google Scholar
• Geva, E. & Jaffe, R.B. (2000). Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertility and Sterility, 74, 429–438.
   PubMed Web of Science ®Google Scholar
• Golan, A. & Weissman, A. (2009). A modern classification of OHSS. Reproductive Biomedicine Online, 19, 28–32.
   PubMed Web of Science ®Google Scholar
• Goldsman, M.P., Pedram, A., Dominguez, C.E., Ciuffardi, I., Levin, E., & Asch, R.H. (1995). Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome.Fertility and Sterility, 63, 268–272.
   PubMed Web of Science ®Google Scholar
• Gordon, J.D., Hopkins, K.L., Jeffrey, R.B., & Giudice, L.C. (1994). Adnexal torsion: color Doppler diagnosis and laparoscopic treatment. Fertility and Sterility, 61, 383–385.
   PubMedGoogle Scholar
• Gorkemli, H., Camus, M., & Clasen, K. (2002). Adnexal torsion after gonadotrophin ovulation induction for IVF or ICSI and its conservative treatment. Archives of Gynecology and Obstetrics, 267, 4–6.
   PubMedGoogle Scholar
• Grossman, L.C., Michalakis, K.G., Browne, H., Payson, M.D., & Segars, J.H. (2010). The pathophysiology of ovarian hyper stimulation syndrome: an unrecognized compartment synd rome. Fertility and Sterility, 94, 1392–1398.
   PubMed Web of Science ®Google Scholar
• Hew-Butler, T., Almond, C., Ayus, J.C., Dugas, J., Meeuwisse, W., Noakes, T., et al.;Exercise-Associated Hyponatremia (EAH) Consensus Panel. (2005). Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clinical Journal of Sport Medicine, 15, 208–213.
   Google Scholar
• HFEA. (2008). A long-term analysis of the HFEA register data 1991–2006 Version 1 Revision 4, Extract date 23/01/2008 http://www.hfea.gov.uk/docs/Latest_long_term_data_analysis_report_91–06.pdf.pdf.
   Google Scholar
• Hitkari, J.A., Rowe, T.P., & von Dadelszen, P. (2006). Activated protein C and the ovarian hyperstimulation syndrome: possible therapeutic implications. Medical Hypotheses, 66, 929–933.
   Google Scholar
• Koninckx, P.R., Renaer, M., & Brosens, I.A. (1980). Origin of peritoneal fluid in women: an ovarian exudation product. British Journal of Obstetrics and Gynaecology, 87, 177–183.
   Google Scholar
• Lainas, T.G., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, G.T., Iliadis, G.S., & Kolibianakis, E.M. (2009). Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol. Reproductive Biomedicine Online, 18, 15–20.
   PubMed Web of Science ®Google Scholar
• Levin, I., Almog, B., Avni, A., Baram, A., Lessing, J.B., & Gamzu, R. (2002). Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertility and Sterility, 77, 986–988.
   PubMed Web of Science ®Google Scholar
• Lincoln, S.R., Opsahl, M.S., Blauer, K.L., Black, S.H., & Schulman, J.D. (2002). Aggressive outpatient treatment of ovarian hyper stimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. Journal of Assisted Reproduction and Genetics, 19, 159–163.
   PubMed Web of Science ®Google Scholar
• Ludwig, M., Bauer, O., Lopens, A., Jelkmann, W., & Diedrich, K. (1998). Serum concentrations of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation. Human Reproduction, 13, 30–32.
   PubMedGoogle Scholar
• Malbrain, M., Cheatham, M., Kirkpatrick, A., Sugrue, M., Parr, M., De Waele, J., et al. (2006). Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Definitions. Intensive Care Medicine, 32, 1722–1732.
   PubMed Web of Science ®Google Scholar
• Manno, M. & Tomei, F. (2008). Renin-angiotensin system activation during severe OHSS: cause or effect?Fertility and Sterility, 89, 488.
   Google Scholar
• Mashiach, S., Bider, D., Moran, O., Goldenberg, M., & Ben-Rafael, Z. (1990). Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertility and Sterility, 53, 76–80.
   PubMed Web of Science ®Google Scholar
• Maslovitz, S., Jaffa, A., Eytan, O., Wolman, I., Many, A., Lessing, J.B., & Gamzu, R. (2004). Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation.Obstetrics & Gynecology, 104, 321–326.
   PubMed Web of Science ®Google Scholar
• Mathur, R.S. & Jenkins, J.M. (2009). Towards a clinically useful classification of OHSS. Reproductive Biomedicine Online, 19, 434.
   Google Scholar
• Mathur, R.S., Akande, A.V., Keay, S.D., Hunt, L.P., & Jenkins, J.M. (2000). Distinction between early and late ovarian hyperstimulation syndrome. Fertility and Sterility, 73, 901–907.
   PubMed Web of Science ®Google Scholar
• Mathur, R., Evbuomwan, I., & Jenkins, J. (2005). Prevention and management of ovarian hyperstimulation syndrome. Current Obstetrics & Gynaecology, 15, 132–138.
   Google Scholar
• Mathur, R., Hayman, G., Bansal, A., & Jenkins, J. (2002). Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception. Fertility and Sterility, 78, 1154–1158.
   PubMed Web of Science ®Google Scholar
• McClure, N., Healy, D.L., Rogers, P.A., Sullivan, J., Beaton, L., Haning, R.V. Jr., et al. (1994). Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235–236.
   PubMed Web of Science ®Google Scholar
• Morris, R.S., Miller, C., Jacobs, L., & Miller, K. (1995). Conservative management of ovarian hyperstimulation syndrome. Journal of Reproductive Medicine, 40, 711–714.
   Google Scholar
• Navot, D., Bergh, P.A., & Laufer, N. (1992). Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertility and Sterility, 58, 249–261.
   PubMed Web of Science ®Google Scholar
• Navot, D., Margalioth, E.J., Laufer, N., Birkenfeld, A., Relou, A., Rosler, A., & Schenker, J.G. (1987). Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertility and Sterility, 48, 57–61.
   PubMed Web of Science ®Google Scholar
• Neulen, J., Yan, Z., Raczek, S., Weindel, K., Keek, C., Weich, H.A., et al. (1995). Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. Journal of Clinical Endocrinology & Metabolism, 80, 1967–1971.
   PubMed Web of Science ®Google Scholar
• Oelsner, G., Cohen, S.B., Soriano, D., Admon, D., Mashiach, S., & Carp, H. (2003). Minimal surgery for the twisted ischaemic adnexa can preserve ovarian function. Human Reproduction, 18, 2599–2602.
   PubMed Web of Science ®Google Scholar
• Ozgun, M.T., Batukan, C., Oner, G., Uludag, S., Aygen, E.M., & Sahin, Y. (2008). Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome. Gynecological Endocrinology, 24, 656–658.
   PubMed Web of Science ®Google Scholar
• Pellicer, A., Albert, C., Mercader, A., Bonilla-Musoles, F., Remohi, J., & Simon, C. (1999). The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1b, interleukin-6, and vascular endothelial growth factor. Fertility and Sterility, 71, 482–489.
   PubMed Web of Science ®Google Scholar
• Pellicer, A., Miro, F., Sampaio, M., Gomez, E., & Bonilla-Musoles, F.M. (1991). In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency. Fertility and Sterility, 55, 970–975.
   PubMedGoogle Scholar
• Pietrowski, D., Szabo, L., Sator, M., Just, A., & Egarter, C. (2011). Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A. Human Reproduction, 27, 196–199. doi:10.1093/humrep/der349.
   Google Scholar
• Reed, A.P., Tausk, H., & Reynolds, H. (1990). Anesthetic considerations for severe ovarian hyperstimulation syndrome. Anesthesiology, 73, 1275–1277.
   Google Scholar
• Rinaldi, M.L. & Spirtos, N.J. (1995). Chest tube drainage of pleural effusion correcting abdominal ascites in a patient with severe ovarian hyperstimulation syndrome: a case report. Fertility and Sterility, 63, 1114–1117.
   PubMed Web of Science ®Google Scholar
• Rizk, B. & Aboulghar, M. (1991). Modern management of ovarian hyperstimulation syndrome. Human Reproduction, 6, 1082–1087.
   PubMed Web of Science ®Google Scholar
• Rollene, N.L., Amols, M.H., Hudson, S.B., & Coddington, C.C. (2009). Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series. Fertility and Sterility, 92, 1169.e15–17.
   Google Scholar
• Shrivastav, P., Nadkarni, P., & Craft, I. (1994). Day care management of severe ovarian hyperstimulation syndrome avoids hospit alization and morbidity. Human Reproduction, 9, 812–814.
   PubMed Web of Science ®Google Scholar
• Shukla, U., Deval, B., Hamoda, H., Savvas, M., & Narvekar, N. (2011). A programme of outpatient surveillance for women at risk of severe OHSS following IVF: A prospective follow-up review of 99 cases. Human Fertility, 14, No. S1: 7.
   Google Scholar
• Simoni, M., Tempfer, C.B., Destenaves, B., & Fauser, B.C.J.M. (2008). Functional genetic polymorphisms and female reproductive disorders: Part 1: polycystic ovary syndrome and ovarian response. Human Reproduction, 14, 459–484.
   Google Scholar
• Smith, L.P., Hacker, M.R., & Alper, M.M. (2009). Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Fertility and Sterility, 92, 1953–1959.
   PubMed Web of Science ®Google Scholar
• Smits, G., Olatunbosun, O., Delbaere, A., Pierson, R., Vassart, G., & Costagliola, S. (2003). Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor.New England Journal of Medicine, 349, 760–766.
   PubMed Web of Science ®Google Scholar
• Strandvik, G.F. (2009). Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia, 64, 990–1003.
   Google Scholar
• Tan, T.S., Tan, K.H., Ng, H.P., & Loh, M.W. (2002). The effects of hypertonic saline solution (7.5%) on coagulation and fibrinolysis: an in vitro assessment using thromboelastography. Anaesthesia, 57, 644–648.
   Google Scholar
• Teruel, M.J., Carbonell, L.F., Teruel, M.G., Parrilla, J.J., Abad, L., & Hernandez, I. (2001). Effect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit.Fertility and Sterility, 76, 1232–1237.
   Google Scholar
• Teruel, M.J., Carbonell, L.F., Llanos, M.C., Parrilla, J.J., Abad, L., & Hernandez, I. (2002). Hemodynamic state and the role of angiotensin II in ovarian hyperstimulation syndrome in the rabbit.Fertility and Sterility, 77, 1256–1260.
   Google Scholar
• Tollan, A., Holst, N., Forsdahl, F., Fadnes, H.O., Oian, P., & Maltau, J.M. (1990). Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization. American Journal of Obstetrics & Gynecology, 162, 554–558.
   PubMed Web of Science ®Google Scholar
• Vardhana, P.A., Julius, M.A., Pollak, S.V., Lustbader, E.G., Trousdale, R.K., & Lustbader, J.W. (2009). A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats. Endocrinology, 150, 3807–3814.
   Google Scholar
• Warren, R.S., Yuan, H., Matli, M.R., Ferrara, N., & Donner, D.B. (1996). Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma. Journal of Biological Chemistry, 271, 483–488.
   Google Scholar
• Whelan, J.G. III. & Vlahos, N.F. (2000). The ovarian hyperstimulation syndrome. Fertility and Sterility, 73, 883–896.
   PubMed Web of Science ®Google Scholar
• Zosmer, A., Katz, Z., Lancet, M., Konichezky, S., & Schwartz-Shoham, Z. (1987). Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome. Fertility and Sterility, 47, 524–526.
   PubMed Web of Science ®Google Scholar